- Home
- TARS vs ARHS Comparison
TARS vs ARHS Comparison
Compare TARS & ARHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- ARHS
- Stock Information
- Founded
- TARS 2016
- ARHS 1986
- Country
- TARS United States
- ARHS United States
- Employees
- TARS N/A
- ARHS N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- ARHS Other Specialty Stores
- Sector
- TARS Health Care
- ARHS Consumer Discretionary
- Exchange
- TARS Nasdaq
- ARHS Nasdaq
- Market Cap
- TARS 1.7B
- ARHS 1.6B
- IPO Year
- TARS 2020
- ARHS 2021
- Fundamental
- Price
- TARS $51.69
- ARHS $11.21
- Analyst Decision
- TARS Strong Buy
- ARHS Buy
- Analyst Count
- TARS 7
- ARHS 13
- Target Price
- TARS $67.14
- ARHS $11.71
- AVG Volume (30 Days)
- TARS 679.4K
- ARHS 1.7M
- Earning Date
- TARS 11-12-2025
- ARHS 11-06-2025
- Dividend Yield
- TARS N/A
- ARHS N/A
- EPS Growth
- TARS N/A
- ARHS N/A
- EPS
- TARS N/A
- ARHS 0.50
- Revenue
- TARS $295,521,000.00
- ARHS $1,335,951,000.00
- Revenue This Year
- TARS $33,170.29
- ARHS $8.41
- Revenue Next Year
- TARS N/A
- ARHS $7.04
- P/E Ratio
- TARS N/A
- ARHS $22.06
- Revenue Growth
- TARS 254.45
- ARHS 4.76
- 52 Week Low
- TARS $30.23
- ARHS $6.61
- 52 Week High
- TARS $59.76
- ARHS $13.97
- Technical
- Relative Strength Index (RSI)
- TARS 46.25
- ARHS 50.49
- Support Level
- TARS $48.20
- ARHS $10.72
- Resistance Level
- TARS $59.76
- ARHS $11.32
- Average True Range (ATR)
- TARS 2.04
- ARHS 0.42
- MACD
- TARS -1.29
- ARHS -0.13
- Stochastic Oscillator
- TARS 30.19
- ARHS 38.36
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About ARHS Arhaus Inc.
Arhaus Inc is a growing lifestyle brand and omnichannel retailer of premium home furniture. The company offers merchandise in several categories, including furniture, outdoor, lighting, textiles, and decor through its Retail and e-commerce sales channels.